Sequence Requirements for Proinsulin Processing at the B-chain/C-peptide Junction

Overview

Journal Biochem J

Specialty Biochemistry

Date 1995 Sep 15

PMID 7575420

Citations 5

Authors

J E Kaufmann

J C Irminger

P A Halban

Affiliations

Soon will be listed here.

Abstract

Proinsulin is converted into insulin by the action of two endoproteases. Type I (PC1/PC3) is thought to cleave between the B-chain and the connecting peptide (C-peptide) and type II (PC2) between the C-peptide and the A-chain. An acidic region immediately C-terminal to the point of cleavage at the B-chain/C-peptide junction is well conserved throughout evolution and has been suggested to be important for proinsulin conversion [Gross, Villa-Komaroff, Kahn, Weir and Halban (1989) J. Biol. Chem. 264, 21486-21490]. We have here compared the precise role of this region as a whole and just the first acidic residue C-terminal to the point of cleavage in processing of proinsulin by PC3. To this end, several mutations were introduced in this region of human proinsulin (native sequence, B-chain RREAEDL C-peptide): RRPAEDL (C1Pro mutant); RRLAEDL (C1Leu mutant); RRL (C1-C4del mutant); RRE (del-C1Glu mutant). Mutant and native cDNAs were stably transfected into AtT20 (pituitary corticotroph) cells, in which PC3 is known to be the major conversion endoprotease, and kinetics of proinsulin conversion were studied (pulse-chase/HPLC analysis of proinsulin-related peptides). The results show that the acidic region following the B-chain/C-peptide junction is indeed important for PC3 cleavage at this site, and that the reduced cleavage observed for the C1-C4del mutant proinsulin can be partially overcome by replacing the acidic region with a single acidic residue (del-C1Glu mutant). Replacing only the first residue of the acidic region with leucine (C1Leu mutant) has no impact on conversion, whereas its replacement with proline (C1Pro mutant) almost completely abolishes cleavage at the B-chain/C-peptide junction without affecting that at the C-peptide/A-chain junction.

Citing Articles

Inside the Insulin Secretory Granule.

Germanos M, Gao A, Taper M, Yau B, Kebede M Metabolites. 2021; 11(8).

PMID: 34436456 PMC: 8401130. DOI: 10.3390/metabo11080515.

Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors.

Sansone A, Lauretta R, Vottari S, Chiefari A, Barnabei A, Romanelli F Cancers (Basel). 2019; 11(8).

PMID: 31382663 PMC: 6721814. DOI: 10.3390/cancers11081113.

Construction of a recombinant human insulin expression vector for mammary gland-specific expression in buffalo (Bubalus bubalis) mammary epithelial cell line.

Kaushik R, Singh K, Kumari A, Rameshbabu K, Singh M, Manik R Mol Biol Rep. 2014; 41(9):5891-902.

PMID: 24969480 DOI: 10.1007/s11033-014-3464-3.

Glucose- and metabolically regulated hepatic insulin gene therapy for diabetes.

Hsu P, Kotin R, Yang Y Pharm Res. 2008; 25(6):1460-8.

PMID: 18293064 DOI: 10.1007/s11095-008-9539-x.

Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus.

Irminger J, Meyer K, Halban P Biochem J. 1996; 320 ( Pt 1):11-5.

PMID: 8947461 PMC: 1217891. DOI: 10.1042/bj3200011.

References

Halban P, Wollheim C . Intracellular degradation of insulin stores by rat pancreatic islets in vitro. An alternative pathway for homeostasis of pancreatic insulin content. J Biol Chem. 1980; 255(13):6003-6. View

Smeekens S, Avruch A, LaMendola J, Chan S, Steiner D . Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans. Proc Natl Acad Sci U S A. 1991; 88(2):340-4. PMC: 50806. DOI: 10.1073/pnas.88.2.340. View

Halban P . Inhibition of proinsulin to insulin conversion in rat islets using arginine and lysine analogs. Lack of effect on rate of release of modified products. J Biol Chem. 1982; 257(22):13177-80. View

Orci L . Macro- and micro-domains in the endocrine pancreas. Diabetes. 1982; 31(6 Pt 1):538-65. DOI: 10.2337/diab.31.6.538. View

Moore H, Walker M, Lee F, Kelly R . Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell. 1983; 35(2 Pt 1):531-8. DOI: 10.1016/0092-8674(83)90187-3. View

Orci L, Ravazzola M, Amherdt M, Madsen O, Vassalli J, Perrelet A . Direct identification of prohormone conversion site in insulin-secreting cells. Cell. 1985; 42(2):671-81. DOI: 10.1016/0092-8674(85)90124-2. View

Orci L . The insulin factory: a tour of the plant surroundings and a visit to the assembly line. The Minkowski lecture 1973 revisited. Diabetologia. 1985; 28(8):528-46. DOI: 10.1007/BF00281987. View

Rholam M, Nicolas P, Cohen P . Precursors for peptide hormones share common secondary structures forming features at the proteolytic processing sites. FEBS Lett. 1986; 207(1):1-6. DOI: 10.1016/0014-5793(86)80002-3. View

Orci L, Ravazzola M, Amherdt M, Madsen O, Perrelet A, Vassalli J . Conversion of proinsulin to insulin occurs coordinately with acidification of maturing secretory vesicles. J Cell Biol. 1986; 103(6 Pt 1):2273-81. PMC: 2114621. DOI: 10.1083/jcb.103.6.2273. View

10.

Cohen R, Given B, Provow S, Rue P, Frank B, ROOT M . Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. Metabolism. 1986; 35(12):1137-46. DOI: 10.1016/0026-0495(86)90027-2. View

11.

Steiner D, Kemmler W, Tager H, Peterson J . Proteolytic processing in the biosynthesis of insulin and other proteins. Fed Proc. 1974; 33(10):2105-15. View

12.

Snell C, Smyth D . Proinsulin: a proposed three-dimensional structure. J Biol Chem. 1975; 250(16):6291-5. View

13.

Steiner D . On the role of the proinsulin C-peptide. Diabetes. 1978; 27 Suppl 1:145-8. DOI: 10.2337/diab.27.1.s145. View

14.

Orci L, Ravazzola M, Storch M, Anderson R, Vassalli J, Perrelet A . Proteolytic maturation of insulin is a post-Golgi event which occurs in acidifying clathrin-coated secretory vesicles. Cell. 1987; 49(6):865-8. DOI: 10.1016/0092-8674(87)90624-6. View

15.

Davidson H, Hutton J . The insulin-secretory-granule carboxypeptidase H. Purification and demonstration of involvement in proinsulin processing. Biochem J. 1987; 245(2):575-82. PMC: 1148160. DOI: 10.1042/bj2450575. View

16.

Davidson H, Rhodes C, Hutton J . Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature. 1988; 333(6168):93-6. DOI: 10.1038/333093a0. View

17.

Lippincott-Schwartz J, Bonifacino J, Yuan L, Klausner R . Degradation from the endoplasmic reticulum: disposing of newly synthesized proteins. Cell. 1988; 54(2):209-20. DOI: 10.1016/0092-8674(88)90553-3. View

18.

Gross D, Skvorak A, HENDRICK G, Weir G, Halban P . Oxidation of rat insulin II, but not I, leads to anomalous elution profiles upon HPLC analysis of insulin-related peptides. FEBS Lett. 1988; 241(1-2):205-8. DOI: 10.1016/0014-5793(88)81062-7. View

19.

Chen C, Bonifacino J, Yuan L, Klausner R . Selective degradation of T cell antigen receptor chains retained in a pre-Golgi compartment. J Cell Biol. 1988; 107(6 Pt 1):2149-61. PMC: 2115669. DOI: 10.1083/jcb.107.6.2149. View

20.

Bonifacino J, Suzuki C, Lippincott-Schwartz J, Weissman A, Klausner R . Pre-Golgi degradation of newly synthesized T-cell antigen receptor chains: intrinsic sensitivity and the role of subunit assembly. J Cell Biol. 1989; 109(1):73-83. PMC: 2115459. DOI: 10.1083/jcb.109.1.73. View